In addition to using the most advanced methods of diagnosis and treatment, James Graham Brown Cancer Center participates and initiates a wide range of ongoing clinical trials and research, examining new approaches to treating lung cancer. Physicians at James Graham Brown Cancer Center are among the top researchers in the world and have initiated and participated in many types of clinical research programs. This includes new therapies that may not yet be available in other parts of the region. To learn more about available clinical trials, talk to your physician.
Clinical Trials and Research
- 05.0523 - Preoperative Metabolomic Analysis of Primary Lung Cancer: a Translational Clinical Trial of the Brown Cancer Center learn more
- 06.0457 - A Randomized, Double-Blind, Placebo-Controlled Phase IIIb Trial Comparing Bevacizumab Therapy with or without Erlotinib After Completion of Chemotherapy with Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer learn more
- 07.0065 - Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer (NSCLC) learn more
- 07.0051 - A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone versus With Temozolomide or Eroltinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases learn more
- 08.0041 - Beta-glucan’s Effect on Cetuximab Induced Cytotoxicity in Non-Small Cell Lung Cancer learn more
- 08.0040 - Berry Interventional Trial (BIT) in Resected Non-Small Cell Lung Cancer learn more
- 04.0565 - Bone Metabolic Markers, TRAP, and Zometa’s Effect on Bone Metastasis due to Lung Cancer (NSCLC/SCLC) learn more
- 06.0622 - Randomized Phase II Trial of Carboplatin and Gemcitabine with or without Dexamethasone in Patients with Untreated Stage IIIB-pleural effusion and Stage IV Non-Small Cell Lung Cancer learn more
- 05.0629 - Phase II Trial of Second Line Erlotinib + Digoxin in Patients with Non-Small Cell Lung Cancer learn more
- 02.0505 - Living Well with Lung Cancer learn more
|